Clinical Alarm Management Market Development | Business Intelligence 2023

According to research report the clinical alarm management market is expected to reach USD 1,724 million by 2023 from an estimated USD 457 million in 2018, at a CAGR of 30.4% during the forecast period. Growth in the clinical alarm management market can be attributed to the increasing alarm fatigue, high prevalence of chronic diseases, growth in the geriatric population, need for cost-containment in healthcare delivery, and rising prominence and usage of big data and mHealth tools.

Download PDF Brchure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69939577

The clinical alarm management market is rapidly emerging with many regional as well as international companies. In 2017, Koninklijke Philips (Netherlands) and Vocera Communications (US), held a share of approximately 70.0% of the clinical alarm management market.

The clinical alarm management market is segmented based on component, product, end user, and region.
• Based on product, the global clinical alarm management market is categorized into nurse call systems, physiological monitors, EMR integration systems, bed alarms, ventilators, and others (infusion pumps and pulse oximeters). The EMR integration systems segment is also expected to grow at the highest rate during the forecast period owing to the increased adoption of EHRs and other interoperability solutions in healthcare organizations, growing regulatory requirements & healthcare reforms, shift of point-of-care diagnostics from hospitals to home care settings, and the need for integrated healthcare systems to improve the quality and outcome of healthcare systems.

• Based on end user, the global clinical alarm management market is segmented into hospitals, long-term care centres, and ambulatory care centres & home care settings. The ambulatory care centres & home care settings segment is expected to register the highest CAGR during the forecast period.

• Based on component, the global clinical alarm management market is segmented into two broad categories based on component, namely— solutions and services. The services segment is expected to grow at the highest CAGR during the forecast period owing to the increasing adoption of clinical alarm management solutions and indispensable and recurring nature of services.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=69939577

The major clinical alarm management vendors include Koninklijke Philips (Netherlands), Vocera Communications (US), Ascom Holdings (Switzerland), Spok, Inc. (US), Bernoulli Enterprise (US), Connexall (Canada), Mobile Heartbeat (US), GE Healthcare (US), Capsule Technologie (US), and Masimo Corporation (US). These players have adopted various growth strategies, such as product launches and enhancements; acquisitions; expansions; and agreements, partnerships, mergers, and collaborations. Product launches and partnerships and have been the most dominating strategy adopted by major players from 2015 to 2018, which helped them to innovate on their offerings and broaden their customer base.

Amniocentesis Needle Market Development | Industry Report 2022

According to the new market research report Amniocentesis Needle Market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. Factors driving the growth of this market include the high accuracy of amniocentesis, increase in the median age of first-time motherhood, and increasing prevalence of congenital disorders.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18541768

Use of amniocentesis needles in amniocentesis procedures drives the global 100–150 mm needles market

This type of needle is suitable for use in females with a normal body-mass index (BMI) of 18.50–24.99 kg/m2. There is an increase in the proportion of women who are overweight, this proportion will still be lesser than the proportion of women with normal BMI. This is one of the major factors responsible for the large share of 100–150 mm needles in the amniocentesis needles market. Amniocentesis procedure is the most commonly recommended invasive prenatal diagnostic test to detect chromosomal disorders, infections, or birth defects. In spite of a small proportion of risks associated with this procedure, amniocentesis is carried out to diagnose the abnormalities in the developing fetus. These are the major factors responsible for the large share of this procedure segment in the amniocentesis needles market.

By procedure, the market is segmented into amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, and cordocentesis. The amniocentesis segment is expected to account for the largest share of the global amniocentesis needles market. Increasing burden of chromosomal disorders, increasing maternal age & BMI, and high reliability of the amniocentesis technique are the major factors responsible for the dominant share of this segment.

Hospitals are estimated to command the largest share of the market during the forecast period
On the basis of end user, the amniocentesis needles market is categorized into hospitals, diagnostic centers, clinics, and other end users. The hospitals segment is estimated to account for the largest share of the global amniocentesis needles market during the forecast period. The presence of expert personnel and advanced medical equipment in hospitals are the key factors driving the growth of this end-user segment.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18541768

The global amniocentesis needles market is dominated by North America, followed by Europe. North America will continue to dominate the global amniocentesis needles market during the forecast period. Factors such as the rising government initiatives and increasing healthcare expenditure are driving the growth of the amniocentesis needles market in this region.

Gel Documentation Systems Market Global Industry Analysis and Forecast to 2023

According to research report the gel documentation systems market size is expected to reach USD 304 million by 2023 from USD 258 million in 2018, at a CAGR of 3.3%. The major factors driving the market are growing global incidence of infectious diseases and genetic disorders and increase in funding for research & development in genomics, proteomics, and electrophoresis techniques.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17162887

Prominent players in the gel documentation systems market include GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), LI-COR Biosciences (US), Endress+Hauser Management AG (Switzerland), Vilber Lourmat (France), Scientific Digital Imaging plc (UK), Bio-Techne (US), Cleaver Scientific (US), and Azure Biosystems (US).

The key strategies followed by most companies in the gel documentation systems market are product launches & approvals, expansions, agreements & collaborations, and acquisitions to achieve growth in the global gel documentation systems market. Product launches accounted for the largest share of the overall growth strategies adopted from 2015 to 2018.

Bio-Rad Laboratories, Inc. was the leading player in the gel documentation systems market. Strong brand recognition and extensive product portfolio in the gel documentation systems market are the company’s key strength. To maintain a leading position in the market, the company focuses on research & development activities to develop and introduce new products in the market. The company invested 11.6%, 10%, and 9.6% of its total revenue in research & development in 2017, 2016, and 2015, respectively. The company launches new products regularly to maintain its dominant presence and promotes its products through various webinars. It recently launched ChemiDoc MP Imaging system. It has a presence in over 30 countries among which, the US is the largest market. The company registered 37% of its revenue from the US in 2017.

GE Healthcare was the second-largest player in the gel documentation systems market. The company offers a wide range of gel documentation systems for protein and nucleic acid quantification. GE’s well-established distribution channels in mature markets, such as North America and Europe, help it to maintain its leading position in the life sciences industry. The company is also focusing on organic growth strategies; for example, it recently entered into an agreement with the Swedish government to open a test centre for innovation in life sciences.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=17162887

Thermo Fisher Scientific was the third-largest player in the global gel documentation market. The company’s leading position in the market can be attributed to its focus on product innovation. It focuses on strengthening its R&D capabilities, core competencies, and meeting customer and market demands. This has helped Thermo Fisher to introduce innovative products in the market. In the last two years, the company launched iBright CL1000 and iBright FL1000 imaging systems. Product launches strengthen the company’s product portfolio, brand recognition, and help the company to maintain its position in the market. The company has a strong presence in more than 150 countries in Europe, North America, South America, Asia Pacific, and Africa.

Healthcare Middleware Market Top Players | Industry Report 2023

According to research report Healthcare Middleware Market is expected to reach USD 3.07 Billion by 2023 from USD 1.90 Billion in 2018, at a CAGR of 10.0%. Increasing utilization of smart devices, the availability of big data in healthcare, increasing need for data interoperability, and growing investments to overcome healthcare interoperability issues are the key drivers of the global market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258951459

InterSystems (US) is well known for its outstanding relationships and commitments with customers and partners, which has positively impacted its business penetration. The company earned its reputation as a preferred vendor by not only offering services to well-known companies such as Epic Systems Corporation and GE Healthcare but also to well-known hospitals in the US. The company’s integrated connected health technology platform—InterSystems Ensemble—is comprehensive and designed to address uncertainties related to healthcare IT implementation and integration.

The company offers cutting-edge technologies and solutions in the healthcare IT integration and middleware segment. It focuses on various strategies like partnerships, agreements, and product enhancements to increase its revenue and expand its business. In January 2016, InterSystems entered a partnership with Pulse Infoframe (US). In February 2018, the company collaborated with ZOLL Medical to improve the bidirectional exchange of patient health information (PHI) between EMS providers, physicians, and emergency departments, accelerating holistic and high-quality patient care delivery. Moreover, in April 2018, the company along with Olympus Corporation (Japan) launched the Knowledge Exchange System (KE) that helps share images taken during endoscopy procedures across healthcare systems.

IBM is one of the leading players in the healthcare middleware market. The company’s strong position in this market can be attributed to its strong brand recognition and extensive product offerings. The company focuses on inorganic as well as organic growth strategies such as acquisitions, partnerships, agreements, collaborations, and product launches in order to expand its existing product portfolio and strengthen its market position. Some of the recently acquired companies include Merge Healthcare (October 2015) and Explorys (April 2015). The company also focused on developing and launching new products such as IBM Cloud Integration (March 2017), IBM Cloud Private Software Platform (November 2017), and new servers and storage software and solutions for cloud computing, and flexible software licensing of its middleware (May 2015). Such product launches enabled the company to strengthen its position in the healthcare middleware market.

Get sample of the report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=258951459

Oracle is one of the leading players in the healthcare middleware market. The company’s leading position can attribute to its immense experience in HCIT, strong brand recognition, and robust portfolio of middleware solutions. The company focuses on increasing its share in the market by introducing innovative products. In this regard, in November 2015, the company launched the Oracle Business Intelligence 12c. In February 2018, the company launched its Oracle Cloud services across Asia, Europe, and the Americas. Such launches helped the company to further sustain its position in this market. Furthermore, the company focuses on adopting inorganic strategies such as acquisitions to strengthen its position in the global healthcare middleware market.

Defibrillators Market Recent Development | Industry Report 2022

According to the new market research report Defibrillators Market is projected to reach USD 10,883.3 million by 2022 from USD 9,323.5 million in 2017 at a CAGR of 3.1%. North America dominated the global defibrillators market in 2017.

The advancements in S-ICDs and MRI-compatible Implantable Cardioverter Defibrillators (ICDs) & Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are also expected to provide growth opportunities for players in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549

Top Market Players -
ZOLL Medical (US) held the leadership position in the global external defibrillators market.
The company adopted new product launches, agreements, and partnerships as its core business strategies to enhance its share in the global external market. Other prominent players in the global external market included Philips (Netherlands), Physio-Control (US), Cardiac Science (US), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey).

• On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds).
• The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). The external defibrillators segment is expected to grow at the highest CAGR in the forecast period, owing to the growing focus of key market players on developing easy-to-use defibrillators, increasing support from governments to install AEDs at public places, and rising adoption of WCDs.
• On the basis of end users, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; alternate care facilities; and home care settings. The public access markets segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the development of advanced AEDs, rising cases of sudden cardiac arrest at out-of-hospital settings, and increasing number of public access defibrillation programs across the globe.

Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=549

Geographic Overview -
North America is expected to account for the largest share of the global defibrillators market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising incidence of target diseases in the region, technological advancements in defibrillators, and increasing number of public defibrillation programs in the region. The large share of the North American market can mainly be attributed to the continuous technological advancements and product innovations, increasing number of public defibrillation programs, and rising focus of key players to expand their business in the North American region.

Clinical Microbiology Market Recent Development | Forecast 2023

According to research report the clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period. Asia Pacific market is expected to grow at the highest CAGR from 2018 to 2023.

The global clinical microbiology market is segmented by product, disease area, end user, and region. On the basis of products, the clinical microbiology market is segmented into instruments, and reagents.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367

• The key players in the industry and markets have been identified through extensive secondary research.
• The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Coverage of new market players, change in market share of existing players
Company profiles offer a glimpse into the workings of key players in the market with respect to business overview, financials, product offerings, and recent developments. In the new edition of the report includes microbiology testing product manufacturers such as QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US). These companies have been profiled as they have emerged as key players in recent time due to the various strategic investments, agreements, and product launches in the microbiology testing space. These strategic developments have challenged the status quo of industry leaders and it was prudent to analyze the changing business landscape.

Updated financial information/ product portfolio of players
Newer and improved representation of financial information: In the latest edition of the microbiology testing/clinical microbiology market report, the market share analysis of top players in the clinical microbiology market has been provided for base year (2017) by extensively studying the financial revenues generated by the major players operating in the clinical microbiology market. The new edition of the report also provides updated financial information in the context of microbiology testing/clinical microbiology market till 2017 for each listed company via a graphical representation in a single diagram (instead of multiple tables). This will help readers to easily analyze the present status of profiled companies in terms of their financial strength, profitability, key revenue generating region/country, and business segment focus (in terms of the highest revenue-generating segment and investment on research and development activities).

Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=219135367

EMS Products Market Recent Development | Industry Report 2022

Emergency medical procedures involve on-the-spot diagnosis and treatment of the critically ill or injured. The emergency medical services EMS products market includes medical products and equipment used for such urgent procedures. This market is expected to reach USD 25.56 billion by 2022 from USD 19.01 billion in 2017, at a CAGR of 6.1%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=195094847

Growth in this market is primarily driven by the high demand for emergency care, increasing incidence of trauma injuries, and growing investments by government bodies on healthcare infrastructure development (including the establishment of and improvements in emergency care infrastructure). However, the high cost of emergency equipment is one of the major factors restraining the growth of this market.

By type, the EMS products market is categorized into patient monitoring equipment, patient handling equipment, wound care products, infection control consumables, personal protection equipment, and life support and emergency resuscitation equipment. The life support and emergency resuscitation equipment segment are expected to grow at the fastest rate during the forecast period. The rising number of emergency visits and the growing requirement of life-support equipment (specially to prevent respiratory or heart failure in critically ill patients) are the major factors supporting the growth of this market segment.

Based on applications, the market is categorized into cardiac care, trauma injuries, respiratory care, oncology, and other applications. The cardiac care segment is estimated to grow at the fastest rate during the forecast period. The growth of this segment can be attributed to the increasing prevalence of cardiovascular disorders and the rising geriatric population.

By end user, the EMS products market is classified into hospitals & trauma centres, ambulatory surgical centres, and other end users. The hospitals & trauma centres segment is estimated to grow at the fastest rate during the forecast period. The rising incidence of chronic conditions and trauma injuries and growth in investments, funds, and grants by government bodies worldwide for hospital infrastructure development are factors driving the growth of this market segment.

Get Report Sample : https://www.marketsandmarkets.com/requestsampleNew.asp?id=195094847

The EMS products market is geographically segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to witness the highest CAGR, with growth cantered in Japan, China, and India. Factors such as large population, rising standards of living, growing demand for quality medical care, and government initiatives are driving the growth of the EMS products market in Asia.

Given the immense opportunities in major applications of EMS products, market leaders and emerging players are increasingly focusing on the market in the segments mentioned above to increase their revenues and are also looking to expand their reach to emerging economies.

Perfusion Systems Market Development | Industry Report 2021

The perfusion systems market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion systems, and cell perfusion systems) and region.

The perfusion systems market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion systems, and cell perfusion systems) and region.
Perfusion systems are used to bypass cardiopulmonary systems in order to treat patients with cardiac and respiratory diseases surgically. Perfusion systems such as heart-lung machines deliver oxygen and remove carbon dioxide in patients when the heart and lungs fail to carry out the process of blood oxygenation. With the increasing prevalence of cardiovascular and respiratory diseases across the globe, the use of perfusion systems is expected to rise in the coming years.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164273069

Perfusion Systems Market Drivers
• Increasing prevalence of cardiovascular and respiratory diseases
• Rising number of organ transplantations
• Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
• Government and NGO Initiatives to Encourage Organ Donation
• Increasing Investments in Cell-Based Research
• Increase in Biologic Manufacturing
Restraints
• High Cost of Organ Transplantation
• Ethical Concerns and High Cost of Cell-Based Research
Opportunities
• Increasing Pharmaceutical Research in Emerging Markets
• Rising Preference for Continuous Manufacturing
Challenges
• Organ Supply-Demand Gap

Increasing prevalence of cardiovascular and respiratory diseases
Cardiovascular diseases are among the leading causes of death globally. They account for about 9.4 million deaths every year. According to the WHO, in 2012, 17.5 million CVD-related deaths (31%) were reported across the globe; this number is expected to grow to more than 23.6 million by 2030. Their high prevalence is in part attributed to the rising prevalence of hypertension, a key risk factor for cardiovascular disease and strokes. In 2013, globally, it was estimated that about 1 billion people suffered from hypertension—a global prevalence of 40%. During the same year, the prevalence of hypertension among adults in Africa was 46% (highest worldwide), while in the Americas, the figure was 35% (the lowest) [Source: WHO]. Similarly, according to the WHO, chronic obstructive pulmonary disease (COPD) caused about 3 million deaths (5%) of the total deaths in 2015. COPD is expected to increase in the coming years due to increasing tobacco consumption and growing pollution.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=164273069

Major Market Developments:
• In January 2015, Medtronic acquired Covidien plc. (Ireland), a manufacturer of healthcare products for use in clinical and home settings worldwide. This acquisition aims to strengthen Medtronic’s customer base and resolve healthcare challenges with constant product development and imbibing new technologies.
• In October 2015, Sorin merged with Cyberonics Inc (US) to form a global medical technology company—LivaNova PLC (U.K.).
• In February 2014, Sorin acquired Bioengineering Laboratories S.p.A. (BEL), a manufacturer of cardiac surgery cannulas. This acquisition is expected to strengthen Sorin’s position in the cardiovascular cannulas market segment.
• In September 2016, Terumo partnered with CytoSorbents Corporation (US), a manufacturer of the CytoSorb extracorporeal blood purification adsorber. Under this partnership, Terumo commercialized the CytoSorb extracorporeal blood purification adsorber for cardiac surgery applications in France, Sweden, Denmark, Norway, Finland, and Iceland.

Sternal Closure Systems Market growing at a CAGR of 5.2% by 2023

According to the new market research report Sternal Closure Systems Market is projected to reach USD 2.61 Billion by 2023 from USD 2.02 Billion in 2018, at a CAGR of 5.2% during the forecast period. The factors driving the growth of this market are the technological advancements in sternotomy techniques, increasing target patient population coupled with the subsequent increase in the number of surgical procedures, and growing availability of medical reimbursements across major markets.
The analysis of the market developments between 2014 and 2018 revealed that several growth strategies such as product launches, mergers, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the sternal closure systems market. Among these business strategies, mergers and acquisitions were the most widely adopted growth strategies.
As of 2017, DePuy Synthes (a part of Johnson & Johnson) (US) is the key manufacturer of the sternal closure products and has a strong position across developed markets such as the US, Germany, and Canada. The company offers two sternal closure products (namely Sternal ZIPFIX and Titanium Sternal Fixation System) for primary or secondary closure/repair of the sternum. The company focuses on R&D activities to maintain its product portfolio. To ensure the development of new products, the company invested USD 9.10 billion in 2016 and USD 10.55 billion in 2017 in R&D activities.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=152164684
As of 2017, Zimmer Biomet (US) is considered a global leader in musculoskeletal healthcare and is one of the leading providers of sternal closure systems in the market. The company’s sternal closure system—SternaLock provides benefits such as increased stability, greater strength, and reduced sternal separation. It also provides additional benefits like a shorter hospital stay, lower risk of bleeding, and shorter recovery time for patients. The company is continuously focusing on research and development activities to expand its product platforms and integrate unique technologies into surgical solutions.
A&E Medical (US) secured the third position in the global sternal closure systems market in 2017. The company manufactures and distributes high-quality products manufactured in the US. The company offers a rigid fixation system consisting of plates and screws, as well as the traditional wire system for sternal closure. The company is focusing on acquisitions as its growth strategy to enhance its position in the global market. In line with this trend, in 2016, the company acquired Medical Concepts (Netherlands). With this acquisition, A&E Medical increased its product portfolio of single-use medical products and extended its geographical footprint in the European market.

Know more: https://www.marketsandmarkets.com/PressReleases/sternal-closure-system.asp

Coronary Stent Market Development | Industry Report 2021

According to the research report the coronary stent market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021. The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

Download Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=77411272

The growth of this market is mainly driven by factors such as technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. Moreover, development of bio resorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market.

The report segments the coronary stent market based on type, mode of delivery, material, end user, and region.

• Based on type, the market is segmented into bare-metal stents, drug-eluting stents and bio absorbable stents. The drug-eluting stents segment is expected to account for the largest share of the coronary stents market in 2016. This can primarily be attributed to the advantages of drug-eluting stents over bare-metal stents, such as lower risk of restenosis and other related complications.
• Based on mode of delivery, the coronary stent market is segmented into balloon-expandable stents and self-expanding stents. The balloon expandable stents segment is expected to grow at the highest CAGR during the forecast period due to factors such as increasing research activities to improve this technology, high utilization of these stents, and growing regulatory approvals for balloon-expandable stents.
• Based on region, the coronary stent market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to dominate the market, followed by Europe. Asia is poised to be the fastest-growing region during the forecast period. Factors such as large population base, growing prevalence of cardiac diseases, rising adoption of advanced technologies, and low manufacturing costs in the region are expected to drive market growth in Asia. Moreover, the growing focus of major players in this region is expected to boost the coronary stents market in Asia.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=77411272

Major Market Developments:

In November 2016, Abbott received approval from the Ministry Of Health, Labor And Welfare (MHLW) (Japan) for its Absorb bioresorbable heart stent. This is the only dissolving heart stent used for the treatment of patients with coronary artery disease in Japan. This approval will help the company expand its presence in the Japanese market.
In January 2016, Abbott acquired St. Jude Medical, Inc. (U.S.), a manufacturer of products for heart failure, atrial fibrillation, and cardiac rhythm management for USD 25 billion. The acquisition helped Abbott to strengthen its coronary intervention product offerings and increase its presence in the cardiovascular devices market
In May 2016, Boston Scientific collaborated with Mayo Clinic (U.S.) to share intellectual property and speed the development of medical devices. This collaboration focuses on the development of medical technologies in the fields of interventional cardiology, heart rhythm management, endoscopy, neuromodulation, urology and pelvic health. This will help the company to strengthen its product offerings.

Oral Care Market – Top Players and Market Growth by 2025

Global Market Size -
The global oral care market is projected to reach USD 53.3 billion by 2025 from USD 44.5 billion in 2019, at a CAGR of 3.0%. Factors such as the rise in the prevalence of dental diseases and the growing awareness about oral healthcare are expected to drive the growth of the market.

Download PDF Brochure - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246

In recent years, product innovation has enabled the development of technologically advanced and easy-to-use oral care products, such as electric, artificial intelligence-equipped (AI), and vibrating toothbrushes. Major players have also launched interactive toothbrushes equipped with position detection and motion sensor technologies. These toothbrushes screen the oral cavity to provide real-time guidance for brushing and maintaining oral health. Electronic toothbrushes have witnessed growing adoption across both developed and developing countries, such as Brazil, Italy, the US, France, and Japan.

Top Leaders -
• Colgate-Palmolive Company (US) is a global leader in the toothpastes and manual toothbrushes market. The company provides advanced oral care products for kids and adults. High investment in R&D enables the company to develop new and advanced toothpastes and toothbrushes for the oral care market. The company invested approximately USD 289 million in 2016 in R&D. Though the company has a rich product portfolio of toothpastes and toothbrushes, the company does not offer denture products and prosthesis cleaning solutions.

• The Procter & Gamble Company (US) is a pioneer in the oral care market. P&G has a strong product portfolio comprising around ten category-based business units and about 65 brands. Its flagship products in the oral care market include Crest and Oral-B toothpastes and toothbrushes. The company aims to focus on the discovery and development of technologically advanced oral care products. For example, the company is currently focusing on the development of a smartphone-connected toothbrush, a device which gives personalized advice to people for brushing.

Some of the other players competing in this market are Unilever plc. (UK), GlaxoSmithKline plc. (UK), Johnson & Johnson (US), Koninklijke Philips N.V. (Netherlands), GC Corporation (Japan), Dr. Fresh, LLC (US), 3M Company (US), Lion Corporation (Japan), Church & Dwight Co, Inc. (US), Sunstar Suisse S.A. (Switzerland), Ivoclar Vivadent AG (Liechtenstein), Henkel AG & Company, KGaA (Germany), Jordan AS (Norway), Panasonic Corporation (Japan), Dentaid Ltd. (UK), Kao Corporation (Japan), LG Household & Health Care Ltd. (South Korea), Dabur India Ltd. (India), The Himalaya Drug Company (India), Patanjali Ayurved Ltd. (India), Supersmile (US), Ranir, LLC. (US), Young Innovations, Inc. (US), and Ultradent Products, Inc. (US).

In this report, the oral care market is categorized based on product, distribution channel, and region. Based on product category, this market is segmented into toothpastes, toothbrushes & accessories, mouthwashes/rinses, dental accessories/ancillaries, denture products, and dental prosthesis cleaning solutions. The toothbrushes and accessories segment is projected to register the highest CAGR during the forecast period. The high growth of this segment is mainly attributed to the increasing adoption of electronic and battery-powered toothbrushes.

Coverage of market players and change in market share of existing players
The report contains the company profiles of key players in this market. These profiles provide detailed information with respect to their business overview, financials, product offerings, recent developments, and MNM view. In the new edition of this report, we have profiled the key market player, and provided in-depth market share analysis for each product category. Market share analsis showcases the position of the key players in global market. The market share analysis provided for the top 3-4 players for each product category of the global oral care/oral hygiene market in 2018.

Get Report Sample - https://www.marketsandmarkets.com/requestsampleNew.asp?id=80546246

Updated company profiles and competitive landscape
The report contains updated financial information for each listed public company from 2016 to 2018; recent developments of the company in the area of oral care market; and the detailed product portfolio of each company. The report also contains MNM views for all the key players profiled in the report. Recent developments help in identifying market trends and popular growth strategies adopted by players in the market.

Veterinary Reference Laboratory Market Top Players | Industry Report - 2024

According to research report Veterinary Reference Laboratory Market is projected to reach a value of USD 4.8 billion by 2024, at a CAGR of 10.7% during the forecast period. In 2018, IDEXX Laboratories, Inc. (US), VCA, Inc. (US), and GD Animal Health (Netherlands) dominated the global veterinary reference laboratories market, accounting for more than 70% of the total market share.

Download Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=256972714

Some of the other prominent players operating in the veterinary reference laboratories market are Zoetis, Inc. (US), Neogen Corporation (US), Boehringer Ingelheim (Germany), Marshfield Labs (US), ProtaTek Internationals, Inc. (US), Texas A&M Veterinary Medical Diagnostic Laboratory (US), Veterinary Diagnostic Laboratory - University of Minnesota (US), and Veterinary Diagnostic Laboratory, Iowa State University (US).

IDEXX Laboratories, Inc. (US) dominated the global veterinary reference laboratories market 2018. The company has a diversified product portfolio, which includes a wide range of companion animal diagnostic products. IDEXX’s leading position in this market can be attributed to its active R&D activities and an extensive distribution footprint across the globe. To garner a larger share in this market, IDEXX continuously focuses on inorganic growth strategies such as acquisitions. The company was involved in the acquisition of five veterinary reference laboratories in FY 2017-18.

VCA, Inc. (US) accounted for the second-largest share of the veterinary reference laboratories market in 2018. The company offers a strong portfolio of products and services in the veterinary diagnostics industry through 65 of its veterinary diagnostic laboratories. VCA provides diagnostic testing for more than 15,000 clients, including standard hospitals for small animals, large animal practices, universities, and other government organizations. The company’s leading position in this market can be attributed to its diagnostic imaging product offerings and consulting services, and its strong relationships with its customers. In order to remain competitive in this market, the company focuses on increasing its customer base. In September 2017, VCA was acquired by one of the leading veterinary health providers, Mars Inc., and now functions as a separate business unit within Mars Petcare.

Get Sample Free Pages: https://www.marketsandmarkets.com/requestsample.asp?id=256972714

North America will continue to dominate the veterinary reference laboratories market in 2024
In 2018, North America accounted for the largest share of the veterinary reference laboratories market, followed by Europe. The increasing adoption of companion animals, the growing pet insurance industry, rising veterinary healthcare expenditure, and the growing number of veterinary practices are driving the growth of the North American veterinary reference laboratories market.

Laboratory Informatics Market Share, Size, Trends and Forecast to 2024

According to research report the laboratory informatics market is estimated to reach USD 3.8 billion by 2024 from USD 2.6 billion in 2019, at a CAGR of 7.5% during the forecast period. Growth in this market is mainly driven by the increasing need for laboratory automation, development of integrated lab informatics solutions, increasing need to comply with regulatory standards, and growing demand in biobanks/biorepositories. On the other hand, the lack of integration standards and high maintenance and service costs are expected to restrain the growth of this market to a certain extent.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633

The laboratory informatics market has been segmented on the basis of type of solution, component, deployment model, industry, and region. Based on type of solution, the laboratory informatics market is segmented into laboratory information management systems (LIMS), electronic lab notebooks (ELN), chromatography data systems (CDS), electronic data capture (EDC) & clinical data management systems (CDMS), laboratory execution systems (LES), enterprise content management (ECM), and scientific data management systems (SDMS). The LIMS segment accounted for the largest share of the laboratory informatics market in 2018. The large share of this segment can be attributed to the wide range of benefits associated with the use of these systems, including increased workflow efficiencies, reduced transcription errors, easy integration with other lab systems, and better regulatory compliance.

On the basis of component, the laboratory informatics market is segmented into software and services. The services segment dominated this market in 2018. Services make up a larger component of the laboratory informatics market due to their indispensable nature. The large share of the services segment can be attributed to the growing technological advancements in solution offerings by various vendors, increasing adoption of cloud-based solutions, growing need for consulting services, and the recurring nature of services.

On the basis of deployment model, the laboratory informatics market is segmented into on-premise, cloud-based, and remotely hosted models. The cloud-based deployment models segment is expected to grow at the highest CAGR during the forecast period. Cloud-based laboratory informatics solutions are sold on the basis of subscription ranging from one month to multiple years and do not require any significant setup charges. No upfront capital investments for hardware, along with extreme capacity flexibility and a pay-as-you-go pricing model, are expected to fuel market growth.

Based on industry, the laboratory informatics market is segmented into life sciences, chemicals, food & beverage and agriculture, petrochemical refineries and oil & gas, environmental testing laboratories, and other industries (forensic laboratories, metal & mining industries, and biofuel industries). The life sciences industry segment accounted for the largest share of the laboratory informatics market in 2018. It is also projected to register the highest CAGR during the forecast period. Federal agency regulations to maintain data integrity, security, and validity are driving life sciences laboratories to adopt laboratory informatics solutions.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=203037633

Geographically, the laboratory informatics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America accounted for the largest market share, followed by Europe. This can be attributed to factors such as growing R&D investments, growing awareness of lab informatics solutions, increase in drug development-based research, and rising pressure to comply with regulatory requirements. In addition to this, the strategic expansion of key players to gain a competitive edge in developing Asian economies further supports the growth of the Asian market.

NPWT devices market Size, Share, Trends | Industry Report 2023

According to research report the NPWT devices market is expected to reach USD 2.72 billion by 2023 from USD 2.11 billion in 2018, at a CAGR of 5.2%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=215139824

The report studies the market on the basis of product type, wound type, end user, and region.
By product type, the NPWT devices market is segmented into conventional NPWT devices, single-use NPWT devices, and accessories. Single-use NPWT devices are expected to account for the fastest growing segment of the market during the forecast period. Single-use NPWT devices are low-cost, small, and discreet NPWT systems, which incorporate simplified functionalities by removing the need for canisters and simplifying the dressing interface, these benefits are driving the growth of this segment.

Based on wound type, the NPWT devices market is segmented into surgical and traumatic wounds, ulcers, and burns. Surgical and traumatic wounds accounted for the fastest growing segment in the NPWT devices market. Market growth can primarily be attributed to the increasing incidence of chronic and acute diseases and supportive government initiatives in the prevention of surgical site infections (SSIs).

By end user, the NPWT devices market is classified into hospitals, home care settings, and other end users. The home care settings segment in NPWT devices market is expected to grow at the fastest rate during the forecast period. The growth of this end-user segment can be attributed to the growing adoption of single-use NPWT devices for home care specifically in developed economies such as the US, the UK, and Germany.

Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=215139824

The NPWT devices market is geographically segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to register the highest CAGR in the market during the forecast period. Growth in this regional segment is largely driven by the large patient population and high prevalence of diabetes in this region.

Thrombectomy Devices Market Development | Industry Report 2022

According to research report thrombectomy devices market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 6.7% during the forecast period.

Over the last few years, the thrombectomy devices market has witnessed significant advancements in terms of the product development and commercialization. The major factors driving the growth of the market are growing target patient population, ongoing technological advancements in thrombectomy devices, favorable medical reimbursement scenario, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222966801

The key players focused on various strategies such as product launches and enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase their shares in the global thrombectomy devices market. Product launches & enhancements is the strategy adopted by major industry players to achieve the desired market growth during 2013-2017.

This strategy was adopted by Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.). Apart from product launches and enhancements, many prominent players also adopted agreements and collaborations as their key growth strategy to strengthen their market presence, enhance their R&D capabilities, and to expand their distribution networks to generate additional demand by sensitizing end users through an increase in availability of thrombectomy devices.

In this report, the market has been segmented by type, application, end user, and region.
In 2016, North America held the largest share of the market.

• Based on type, the market is segmented into aspiration, mechanical, rheolytic, and ultrasonic thrombectomy devices. The ultrasonic thrombectomy devices segment is poised to be the fastest growing during the forecast period. The growing demand for ultrasonic thrombectomy devices can primarily be attributed to factors such as rising adoption of ultrasonic thrombectomy products by medical professionals, higher therapeutic efficacy for the treatment of deep vein thrombosis and pulmonary embolism, and its affordability.
• On the basis of application, the market is segmented into cardiovascular, neurovascular, and peripheral vascular applications. Peripheral vascular segment is expected to be the fastest growing in the market during the forecast period. This growth can be attributed to the rising availability of medical reimbursements for peripheral thrombectomy procedures across major markets, rising incidence of vascular disorders across the globe, growing geriatric population, ongoing technological advancements in the field of vascular ultrasound treatment, and rising awareness related to clinical efficacy of thrombectomy procedures in PVD treatment.

Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=222966801

By end user, the market is segmented into hospitals & surgical centers, ambulatory surgical centers, research laboratories & academic institutes, and other end users. Ambulatory surgical centers (ASCs) are expected to be the fastest growing end user segment in the market. This high growth can be attributed to the increasing availability of reimbursement for thrombectomy procedures in outpatient settings, ongoing advancements in minimally invasive surgical techniques, increasing number of image-guided surgeries performed at ASCs, and rising market demand for miniaturized therapeutic devices.